Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Perillyl Alcohol in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

ClinicalTrials.gov ID: NCT00003238

Public ClinicalTrials.gov record NCT00003238. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 30, 2026, 12:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Trial of Perillyl Alcohol (NSC 641066) Administered Daily In Patients With Metastatic Androgen Independent Prostate Cancer

Study identification

NCT ID
NCT00003238
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
University of Wisconsin, Madison
Other
Enrollment
Not listed

Conditions and interventions

Interventions

  • perillyl alcohol Drug

Drug

Eligibility (public fields only)

Age range
Up to 120 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 1998
Primary completion
Sep 30, 2001
Completion
Not listed
Last update posted
Dec 12, 2019

Started 1998

United States locations

U.S. sites
8
U.S. states
2
U.S. cities
7
Facility City State ZIP Site status
Leonard C. Ferguson Cancer Center Freeport Illinois 61032
Green Bay Oncology, Ltd. Green Bay Wisconsin 54307-3453
Mercy Health System Janesville Wisconsin 53545
Gundersen Lutheran Medical Center La Crosse Wisconsin 54601
Meriter Hospital Madison Wisconsin 53715
University of Wisconsin Comprehensive Cancer Center Madison Wisconsin 53792
Sinai Samaritan Medical Center - Milwaukee Milwaukee Wisconsin 53201-0342
North Central Oncology Associates, S.C. Wausau Wisconsin 54401

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00003238, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 12, 2019 · Synced Apr 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00003238 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →